Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

26.47
Delayed Data
As of Dec 07
 -1.77 / -6.27%
Today’s Change
14.84
Today|||52-Week Range
34.90
-14.53%
Year-to-Date
Julian Robertson Sells Delta Air Lines, Alphabet
Dec 07 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close28.24
Today’s open27.79
Day’s range25.95 - 28.48
Volume209,145
Average volume (3 months)237,129
Market cap$983.8M
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-143.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-1.15-5.31%
AMPHAmphastar Pharmaceut...-1.23-5.89%
SGYPSynergy Pharmaceutic...-0.13-2.32%
IPXLImpax Laboratories I...0.000.00%
Data as of 12/07/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs